A new treatment was developed to slow down the progression of ALS. Steven-Johnson syndrome was reported as a side effect of the medication. | Medibuddy
14th February 2024

A new treatment was developed to slow down the progression of ALS. Steven-Johnson syndrome was reported as a side effect of the medication.

A new treatment was developed to slow down the progression of ALS. Steven-Johnson syndrome was reported as a side effect of the medication. A study of 500 patients was carried out, with 200 patients having had the new medication. Steven-Johnson syndrome was reported in 10 patients taking the new medication. 2 cases were noted in the placebo group. 

What is the number needed to harm for this medication? 

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.